Verdicts genuinely change. Free email alert the moment CURE's does — no target price to set, unlike "Alert" above.
Whether this fund clears the published standards, and the filings behind that answer. The screen runs first and nothing on the trading side can override it.
Structure, momentum, positioning and levels. Separate from the Sharia verdict above, which this side never overrides.
Direxion Daily Healthcare Bull 3X Shares ETF · Direxion Shares ETF Trust
67 holdings · as of 2026-07-31 (2.4 months ago)
This fund holds short positions, so exposure is counted gross — long and short both count as exposure rather than netting off, and the weights below therefore sum to 115% of net assets rather than 100%. Shares of the portfolio are shown as shares of that gross exposure.
NON-COMPLIANT At least 14.69% of portfolio weight is in non-compliant holdings — already over the 5% threshold, so the verdict is settled whatever the unmatched 49% turns out to be. Matching more holdings can only raise this share, never lower it.
67 holdings, 57 matched (57% of weight). Portfolio as of 2026-07-31, filed 2026-09-28. Source: SEC Form N-PORT.
0.88% of this portfolio’s income is non-permissible — weighted across holdings, computed over 49% of portfolio weight (51 of 67 holdings). The common approach purifies that proportion of income received — dividends — not of the position’s value. We report the ratio; what to do with it is a question for your own scholar.
Portfolio shares are withheld: coverage is below the floor needed to state one. The holdings themselves are below, because the names are evidence you can check.
| Holding | Status | Weight | Every methodology, and the debt ratio behind it |
|---|---|---|---|
| DREYFUS | UNSCREENED | 18.79% | no in-house ratios for this holding |
| LLY ELI LILLY & COMPANY | COMPLIANT | 10.41% | AAOIFI5.2% Usmani38.6% Dow Jones Islamic6.4% S&P Shariah6.9% MSCI Islamic38.6% MSCI Islamic M-Series6.9% FTSE Shariah38.6% |
| N/A | UNSCREENED | 8.28% | no in-house ratios for this holding |
| GOLDMAN SACHS LIQ ES FD A | UNSCREENED | 8.19% | no in-house ratios for this holding |
| GOLDMAN FINANCIAL | UNSCREENED | 7.51% | no in-house ratios for this holding |
| JNJ JOHNSON & JOHNSON | COMPLIANT | 7.07% | AAOIFI7.6% Usmani24.4% Dow Jones Islamic10.9% S&P Shariah11.7% MSCI Islamic24.4% MSCI Islamic M-Series11.7% FTSE Shariah24.4% |
| ABBV ABBVIE INC | COMPLIANT | 5.08% | AAOIFIpass Usmanifail Dow Jones Islamicpass S&P Shariahpass MSCI Islamicfail MSCI Islamic M-Seriespass FTSE Shariahfail |
| UNH UNITEDHEALTH GROUP INC | NON_COMPLIANT | 4.31% | AAOIFI20.4% Usmani23.7% Dow Jones Islamic20.4% S&P Shariah18.8% MSCI Islamic23.7% MSCI Islamic M-Series18.8% FTSE Shariah23.7% |
| MRK MERCK & COMPANY INC | COMPLIANT | 3.68% | AAOIFI14.7% Usmani41.5% Dow Jones Islamic21.8% S&P Shariah20.9% MSCI Islamic41.5% MSCI Islamic M-Series20.9% FTSE Shariah41.5% |
| N/A | UNSCREENED | 3.34% | no in-house ratios for this holding |
| TMO THERMO FISHER SCIENTIFIC INC | COMPLIANT | 2.45% | AAOIFI20.5% Usmani40.3% Dow Jones Islamic23.4% S&P Shariah22.9% MSCI Islamic40.3% MSCI Islamic M-Series22.9% FTSE Shariah40.3% |
| AMGN AMGEN INC | COMPLIANT | 2.38% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| ABT ABBOTT LABORATORIES | COMPLIANT | 2.11% | AAOIFI19.2% Usmani31.9% Dow Jones Islamic17.6% S&P Shariah18.3% MSCI Islamic31.9% MSCI Islamic M-Series18.3% FTSE Shariah30.8% |
| GILD GILEAD SCIENCES INC | COMPLIANT | 1.85% | AAOIFI14.4% Usmani53.2% Dow Jones Islamic18.6% S&P Shariah21.4% MSCI Islamic53.2% MSCI Islamic M-Series21.4% FTSE Shariah53.2% |
| PFE PFIZER INC | NON_COMPLIANT | 1.63% | AAOIFI39.8% Usmani31.4% Dow Jones Islamic46.1% S&P Shariah45.9% MSCI Islamic31.4% MSCI Islamic M-Series45.9% FTSE Shariah31.4% |
| BMY BRISTOL-MYERS SQUIBB CO | NON_COMPLIANT | 1.53% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| CVS CVS HEALTH CORP | NON_COMPLIANT | 1.53% | AAOIFI61.7% Usmani30.1% Dow Jones Islamic84.9% S&P Shariah88.7% MSCI Islamic30.1% MSCI Islamic M-Series88.7% FTSE Shariah24.2% |
| ISRG INTUITIVE SURGICAL INC | COMPLIANT | 1.43% | AAOIFI0.0% Usmani0.0% Dow Jones Islamic0.0% S&P Shariah0.0% MSCI Islamic0.0% MSCI Islamic M-Series0.0% FTSE Shariah0.0% |
| DHR DANAHER CORP | COMPLIANT | 1.41% | AAOIFI18.2% Usmani28.8% Dow Jones Islamic17.7% S&P Shariah16.7% MSCI Islamic28.8% MSCI Islamic M-Series16.7% FTSE Shariah28.8% |
| VRTX VERTEX PHARMACEUTICALS INC | COMPLIANT | 1.39% | AAOIFI1.6% Usmani7.2% Dow Jones Islamic1.7% S&P Shariah1.7% MSCI Islamic7.2% MSCI Islamic M-Series1.7% FTSE Shariah0.0% |
| SYK STRYKER CORP | COMPLIANT | 1.29% | AAOIFI14.6% Usmani32.2% Dow Jones Islamic11.3% S&P Shariah11.8% MSCI Islamic32.2% MSCI Islamic M-Series11.8% FTSE Shariah31.2% |
| MDT MEDTRONIC PLC | COMPLIANT | 1.26% | AAOIFI24.4% Usmani31.5% Dow Jones Islamic26.4% S&P Shariah27.4% MSCI Islamic31.4% MSCI Islamic M-Series27.4% FTSE Shariah30.2% |
| MCK MCKESSON CORP | COMPLIANT | 1.18% | AAOIFI12.5% Usmani14.9% Dow Jones Islamic14.5% S&P Shariah15.8% MSCI Islamic14.7% MSCI Islamic M-Series15.8% FTSE Shariah12.5% |
| N/A | UNSCREENED | 1.12% | no in-house ratios for this holding |
| ANTHEM INC | UNSCREENED | 0.94% | no in-house ratios for this holding |
| REGN REGENERON PHARMACEUTICALS INC | COMPLIANT | 0.87% | AAOIFI2.4% Usmani6.5% Dow Jones Islamic3.0% S&P Shariah2.7% MSCI Islamic4.8% MSCI Islamic M-Series2.7% FTSE Shariah4.8% |
| CI THE CIGNA GROUP | NON_COMPLIANT | 0.85% | AAOIFI42.7% Usmani20.3% Dow Jones Islamic40.5% S&P Shariah38.8% MSCI Islamic20.3% MSCI Islamic M-Series38.8% FTSE Shariah20.3% |
| BSX BOSTON SCIENTIFIC CORP | COMPLIANT | 0.80% | AAOIFI19.4% Usmani27.9% Dow Jones Islamic10.0% S&P Shariah10.9% MSCI Islamic27.9% MSCI Islamic M-Series10.9% FTSE Shariah27.9% |
| HCA HCA HEALTHCARE INC | NON_COMPLIANT | 0.72% | AAOIFI57.2% Usmani82.9% Dow Jones Islamic53.5% S&P Shariah56.7% MSCI Islamic81.7% MSCI Islamic M-Series56.7% FTSE Shariah78.1% |
| AMERISOURCEBERGEN CORP | UNSCREENED | 0.69% | no in-house ratios for this holding |
| CAH CARDINAL HEALTH INC | COMPLIANT | 0.62% | AAOIFI17.8% Usmani17.7% Dow Jones Islamic24.8% S&P Shariah28.7% MSCI Islamic17.4% MSCI Islamic M-Series28.7% FTSE Shariah15.5% |
| EW EDWARDS LIFESCIENCES CORP | COMPLIANT | 0.57% | AAOIFI1.4% Usmani5.1% Dow Jones Islamic1.5% S&P Shariah1.5% MSCI Islamic5.1% MSCI Islamic M-Series1.5% FTSE Shariah4.3% |
| N/A | UNSCREENED | 0.57% | no in-house ratios for this holding |
| BDX BECTON DICKINSON AND CO | NON_COMPLIANT | 0.52% | AAOIFI33.4% Usmani33.1% Dow Jones Islamic30.8% S&P Shariah28.7% MSCI Islamic33.1% MSCI Islamic M-Series28.7% FTSE Shariah33.1% |
| IDXX IDEXX LABORATORIES INC | COMPLIANT | 0.51% | AAOIFI1.4% Usmani16.8% Dow Jones Islamic1.3% S&P Shariah1.3% MSCI Islamic16.8% MSCI Islamic M-Series1.3% FTSE Shariah13.1% |
| HUM HUMANA INC | NON_COMPLIANT | 0.50% | AAOIFI30.1% Usmani26.3% Dow Jones Islamic44.9% S&P Shariah38.8% MSCI Islamic26.3% MSCI Islamic M-Series38.8% FTSE Shariah25.3% |
| IQV IQVIA HOLDINGS INC | NON_COMPLIANT | 0.45% | AAOIFI36.7% Usmani55.2% Dow Jones Islamic47.8% S&P Shariah44.8% MSCI Islamic54.4% MSCI Islamic M-Series44.8% FTSE Shariah53.4% |
| A AGILENT TECHNOLOGIES INC | COMPLIANT | 0.45% | AAOIFI9.3% Usmani28.3% Dow Jones Islamic10.8% S&P Shariah10.7% MSCI Islamic28.3% MSCI Islamic M-Series10.7% FTSE Shariah28.3% |
| WAT WATERS CORP | COMPLIANT | 0.42% | AAOIFI14.1% Usmani21.2% Dow Jones Islamic21.2% S&P Shariah23.3% MSCI Islamic21.2% MSCI Islamic M-Series23.3% FTSE Shariah19.7% |
| ZTS ZOETIS INC | NON_COMPLIANT | 0.37% | AAOIFI29.0% Usmani61.3% Dow Jones Islamic15.4% S&P Shariah14.0% MSCI Islamic61.3% MSCI Islamic M-Series14.0% FTSE Shariah60.0% |
| DXCM DEXCOM INC | COMPLIANT | 0.37% | AAOIFI4.1% Usmani21.7% Dow Jones Islamic4.7% S&P Shariah4.0% MSCI Islamic20.9% MSCI Islamic M-Series4.0% FTSE Shariah19.3% |
| GEHC GE HEALTHCARE TECHNOLOGIES INC | NON_COMPLIANT | 0.35% | AAOIFI34.9% Usmani28.5% Dow Jones Islamic30.2% S&P Shariah30.1% MSCI Islamic28.4% MSCI Islamic M-Series30.1% FTSE Shariah27.3% |
| RMD RESMED INC | COMPLIANT | 0.35% | AAOIFI2.6% Usmani9.2% Dow Jones Islamic2.4% S&P Shariah2.6% MSCI Islamic9.2% MSCI Islamic M-Series2.6% FTSE Shariah7.4% |
| VEEV VEEVA SYSTEMS INC | NON_COMPLIANT | 0.35% | AAOIFI0.4% Usmani1.7% Dow Jones Islamic0.4% S&P Shariah0.4% MSCI Islamic1.7% MSCI Islamic M-Series0.4% FTSE Shariah0.0% |
| BIIB BIOGEN INC | COMPLIANT | 0.34% | AAOIFI21.2% Usmani22.5% Dow Jones Islamic27.5% S&P Shariah24.3% MSCI Islamic22.5% MSCI Islamic M-Series24.3% FTSE Shariah21.3% |
| CNC CENTENE CORP | NON_COMPLIANT | 0.33% | AAOIFI50.5% Usmani19.4% Dow Jones Islamic62.6% S&P Shariah53.4% MSCI Islamic19.4% MSCI Islamic M-Series53.4% FTSE Shariah19.4% |
| MTD METTLER-TOLEDO INTERNATIONAL | COMPLIANT | 0.33% | AAOIFI7.8% Usmani57.5% Dow Jones Islamic8.0% S&P Shariah7.9% MSCI Islamic57.5% MSCI Islamic M-Series7.9% FTSE Shariah57.5% |
| DGX QUEST DIAGNOSTICS INC | COMPLIANT | 0.30% | AAOIFI24.4% Usmani37.7% Dow Jones Islamic32.1% S&P Shariah35.4% MSCI Islamic37.7% MSCI Islamic M-Series35.4% FTSE Shariah33.3% |
| LH LABCORP HOLDINGS INC | COMPLIANT | 0.29% | AAOIFI25.4% Usmani36.5% Dow Jones Islamic31.6% S&P Shariah33.5% MSCI Islamic36.2% MSCI Islamic M-Series33.5% FTSE Shariah31.6% |
| WST WEST PHARMACEUTICAL SERVICES | COMPLIANT | 0.28% | AAOIFI1.3% Usmani7.8% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic7.7% MSCI Islamic M-Series1.4% FTSE Shariah5.0% |
| STE STERIS PLC | COMPLIANT | 0.26% | AAOIFI9.4% Usmani19.1% Dow Jones Islamic9.1% S&P Shariah9.3% MSCI Islamic19.1% MSCI Islamic M-Series9.3% FTSE Shariah17.6% |
| VTRS VIATRIS INC | NON_COMPLIANT | 0.23% | AAOIFI65.8% Usmani38.9% Dow Jones Islamic100.2% S&P Shariah105.1% MSCI Islamic38.9% MSCI Islamic M-Series105.1% FTSE Shariah38.1% |
| INCY INCYTE CORP | COMPLIANT | 0.23% | AAOIFI0.1% Usmani0.7% Dow Jones Islamic0.1% S&P Shariah0.1% MSCI Islamic0.3% MSCI Islamic M-Series0.1% FTSE Shariah0.0% |
| MRNA MODERNA INC | NON_COMPLIANT | 0.22% | AAOIFI2.2% Usmani11.7% Dow Jones Islamic7.4% S&P Shariah5.1% MSCI Islamic11.4% MSCI Islamic M-Series5.1% FTSE Shariah5.4% |
| ZBH ZIMMER BIOMET HOLDINGS INC | NON_COMPLIANT | 0.21% | AAOIFI40.7% Usmani32.8% Dow Jones Islamic39.1% S&P Shariah36.3% MSCI Islamic32.8% MSCI Islamic M-Series36.3% FTSE Shariah32.8% |
| COO COOPER COS INC/THE | COMPLIANT | 0.16% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| BAX BAXTER INTERNATIONAL INC | NON_COMPLIANT | 0.15% | AAOIFI1.7% Usmani1.1% Dow Jones Islamic1.6% S&P Shariah1.4% MSCI Islamic1.1% MSCI Islamic M-Series1.4% FTSE Shariah0.0% |
| SOLV SOLVENTUM CORP | NON_COMPLIANT | 0.14% | AAOIFI32.5% Usmani37.1% Dow Jones Islamic39.6% S&P Shariah41.1% MSCI Islamic35.7% MSCI Islamic M-Series41.1% FTSE Shariah35.7% |
| RVTY REVVITY INC | COMPLIANT | 0.14% | AAOIFI23.1% Usmani27.9% Dow Jones Islamic27.9% S&P Shariah27.2% MSCI Islamic27.9% MSCI Islamic M-Series27.2% FTSE Shariah26.7% |
| PODD INSULET CORP | COMPLIANT | 0.13% | AAOIFI9.6% Usmani30.0% Dow Jones Islamic5.3% S&P Shariah5.9% MSCI Islamic30.0% MSCI Islamic M-Series5.9% FTSE Shariah30.0% |
| TECH BIO-TECHNE CORP | COMPLIANT | 0.13% | AAOIFI2.5% Usmani11.2% Dow Jones Islamic3.0% S&P Shariah2.9% MSCI Islamic11.2% MSCI Islamic M-Series2.9% FTSE Shariah7.7% |
| ALGN ALIGN TECHNOLOGY INC | COMPLIANT | 0.13% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| CRL CHARLES RIVER LABORATORIES INTERNATIONAL INC | COMPLIANT | 0.13% | AAOIFI— Usmani— Dow Jones Islamic— S&P Shariah— MSCI Islamic— MSCI Islamic M-Series— FTSE Shariah— |
| UHS UNIVERSAL HEALTH SVCS | NON_COMPLIANT | 0.10% | AAOIFI52.8% Usmani33.0% Dow Jones Islamic45.9% S&P Shariah48.2% MSCI Islamic33.0% MSCI Islamic M-Series48.2% FTSE Shariah30.4% |
| HSIC HENRY SCHEIN INC | NON_COMPLIANT | 0.10% | AAOIFI36.7% Usmani32.3% Dow Jones Islamic41.6% S&P Shariah41.0% MSCI Islamic32.3% MSCI Islamic M-Series41.0% FTSE Shariah29.2% |
| DVA DAVITA INC | NON_COMPLIANT | 0.09% | AAOIFI119.4% Usmani75.7% Dow Jones Islamic119.5% S&P Shariah122.0% MSCI Islamic75.7% MSCI Islamic M-Series122.0% FTSE Shariah60.9% |
| HOLOGIC INC- CVR | UNSCREENED | 0.00% | no in-house ratios for this holding |
The published standards disagree about this fund by 22 points of portfolio weight — 50.7% of it passes S&P Shariah, 28.5% passes MSCI Islamic. Which number is yours depends on which standard you follow.
These bars are the financial-ratio result under each standard — debt, receivables and interest income. They do not screen what the business does, so a holding can pass every ratio here and still be questionable or non-compliant on activity. The blended verdict above accounts for both.
ratios pass on 50.4% ratios fail on 9.2% 55.3% not rated under AAOIFI
ratios pass on 30.4% ratios fail on 29.2% 55.3% not rated under Usmani
ratios pass on 49.5% ratios fail on 10.1% 55.3% not rated under Dow Jones Islamic
ratios pass on 50.7% ratios fail on 8.9% 55.3% not rated under S&P Shariah
ratios pass on 28.5% ratios fail on 32.5% 53.9% not rated under MSCI Islamic
ratios pass on 50.1% ratios fail on 9.5% 55.3% not rated under MSCI Islamic M-Series
ratios pass on 31.3% ratios fail on 28.3% 55.3% not rated under FTSE Shariah
57 of 67 listed holdings carry our own per-methodology verdicts (65% of weight). The rest hold a provider verdict with no methodology breakdown, and are counted as rated by none. Of those, 51 (56% of weight) also carry the underlying debt ratio; the rest show a verdict without the figure behind it.
| Non-compliant holding | Weight |
|---|---|
| UNH UNITEDHEALTH GROUP INC | 4.31% |
| PFE PFIZER INC | 1.63% |
| BMY BRISTOL-MYERS SQUIBB CO | 1.53% |
| CVS CVS HEALTH CORP | 1.53% |
| CI THE CIGNA GROUP | 0.85% |
| HCA HCA HEALTHCARE INC | 0.72% |
| BDX BECTON DICKINSON AND CO | 0.52% |
| HUM HUMANA INC | 0.50% |
| IQV IQVIA HOLDINGS INC | 0.45% |
| ZTS ZOETIS INC | 0.37% |
Methodology breakdown computing — it will appear here on its own.
Whether the technical picture shows an edge right now. Separate from the Sharia verdict, which this side never overrides.
The factors behind the read, each shown with the figure it rests on, including the ones pointing the other way.
Direxion Daily Healthcare Bull 3X Shares (CURE) is currently considered not halal (non-compliant), per our own look-through to its filed holdings. See its filed holdings and the weight breakdown below for the reasoning.
Still fetching analyst coverage — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.
Computing the full ratio and business-activity breakdown for CURE — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally below. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 58.50 | NEUTRAL |
| Stochastic %K (14) | 93.44 | SELL |
| CCI (20) | 132.96 | SELL |
| Williams %R (14) | -6.56 | SELL |
| MACD (12,26,9) | 0.52 | BUY |
| ROC (10) | 0.38 | BUY |
| Momentum (10) | 0.51 | BUY |
| EMA (10) | 130.72 | BUY |
| SMA (10) | 129.30 | BUY |
| EMA (20) | 130.39 | BUY |
| SMA (20) | 130.02 | BUY |
| EMA (30) | 130.08 | BUY |
| SMA (30) | 130.32 | BUY |
| EMA (50) | 128.06 | BUY |
| SMA (50) | 131.22 | BUY |
| EMA (100) | 121.45 | BUY |
| SMA (100) | 119.14 | BUY |
| EMA (200) | 114.12 | BUY |
| SMA (200) | 110.37 | BUY |
The fund invests at least 80% of its net assets in financial instruments, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective. The index includes domestic companies from the healthcare sector, which includes: pharmaceuticals; health care equipment and supplies; health care providers and services; biotechnology; life sciences tools and services; and health care technology. It is non-diversified.
Background via Yahoo Finance — informational, not part of the verdict.
Average — needs more confirmation before sizing up
Market structure by timeframe, read from real bars. A bias per timeframe rather than a forecast — timeframes disagreeing is information, not noise.
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 42 |
| ⏰ 4H | NEUTRAL | 17 |
| 🕐 1H | BULLISH | 71 |
| ⏱ 15-Min | BULLISH | 130 |
| ⏲ 5-Min | BEARISH | 234 |
Rate of change and relative volume against this symbol's own recent history. Momentum describes what price has done; it is not a claim about what it will do.
How the rest of the sector moved over the same window. Context for a price move, never a cause of one.
Peer movement computing — it will appear here on its own.
The questions worth asking about any verdict on this page, answered plainly.
No. HTR reads the fund's filed holdings and screens each one, then reports the result by weight. A fund marketed as Islamic still gets the same look-through as any other.
It is the share of the fund whose holdings HTR cannot cover far enough to rate. It is reported as unrated rather than counted as compliant, because a holding nobody screened should not look like one that passed.
It matters, and it is noted, but it does not replace the look-through. The board's judgement and the holdings screen are shown separately so you can see when they agree and when they do not.
When the fund files new holdings, and on a rolling basis besides. The date on the verdict above is the last time this fund was actually recomputed.
Open research, not a fatwa. HTR applies published screening standards to filings and publishes what they say, including when they disagree. Nothing here is financial advice or a recommendation to buy or sell. Verdicts can change when new filings land.
Same screen, different answers. Comparison is where the standards disagreeing becomes useful rather than confusing.
Peer screening computing — it will appear here on its own.
Still fetching insider filings — it ran past this page's budget, so the page painted without waiting. The fetch is still running; reload in a moment and it will be here.
The weekly CFTC Commitments of Traders report for the broad market it tracks, not for this symbol. Positioning context for the tape — it says nothing about this company.
NEUTRAL report date 2026-10-06 · Asset managers net 906615 (+2612)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.